[On the inhibitory effect of metal salts on experimental vascular calcinosis].
D000085:Acetates; D000818:Animals; D001011:Aorta / Q000473:pathology; D001158:Arteries / Q000473:pathology; D001366:Axillary Artery / Q000473:pathology; D002114:Calcinosis / Q000139:chemically induced / Q000473:pathology*; D002339:Carotid Arteries / Q000473:pathology; D002712:Chlorides; D003035:Cobalt / Q000494:pharmacology*; D003331:Coronary Vessels / Q000473:pathology; D004097:Dihydrotachysterol / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D005260:Female; D005263:Femoral Artery / Q000473:pathology; D006652:Histological Techniques; D007274:Injections, Intraperitoneal; D007505:Iron-Dextran Complex / Q000494:pharmacology*; D007668:Kidney / Q000473:pathology; D008274:Magnesium / Q000494:pharmacology*; D008345:Manganese / Q000494:pharmacology*; D009206:Myocardium / Q000473:pathology; D009397:Nephrocalcinosis / Q000139:chemically induced / Q000473:pathology*; D051381:Rats; D014652:Vascular Diseases / Q000139:chemically induced / Q000473:pathology*; D015032:Zinc / Q000494:pharmacology*
D000085:Acetates; D002712:Chlorides; D003035:Cobalt; D008345:Manganese; D007505:Iron-Dextran Complex; D008274:Magnesium; D015032:Zinc; D004097:Dihydrotachysterol
Zur hemmwirkung von Metallsalzen auf die experimentelle Gefässcalcinose.